# Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging

> **NCT02311556** · PHASE1 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 23 (actual)

## Conditions studied

- Brain Metastases

## Interventions

- **DEVICE:** dynamic susceptibility-weighted contrast-enhanced perfusion magnetic resonance imaging

## Key facts

- **NCT ID:** NCT02311556
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-07
- **Primary completion:** 2016-07-01
- **Final completion:** 2016-12-16
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2017-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02311556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02311556, "Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging". Retrieved via MORVS 2026-10-17 from https://api.morvs.ai/clinical/NCT02311556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*